SOX2 and lung adenocarcinoma: Moreover, a previously characterized OCT4/SOX2/NANOG embryonic stem cell expression signature [11] effectively separated SCCs from lung adenocarcinomas when analyzed in publicly available NSCLC microarray datasets.